Coma, hyperammonemia, metabolic acidosis, and mutation: Lessons learned in the acute management of late onset urea cycle disorders

Hemodialysis International

Volumn 16, Issue 1, 2012, Pages 95-100

  Iyer, Hari ^a   Sen, Mithu ^a   Prasad, Chitra ^a   Rupar, C Anthony ^a   Lindsay, Robert M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Coma; Hemodialysis; Hyperammonemia; Metabolic acidosis; Mutation; Ornithine transcarbamylase; Urea cycle; X linked

Indexed keywords

ADIPHENINE; ARGININE; BENZOIC ACID; HIPPURIC ACID; OROTIC ACID;

ADULT; AMMONIA BLOOD LEVEL; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BABINSKI REFLEX; BICARBONATE BLOOD LEVEL; BLOOD CELL COUNT; BRAIN DISEASE; BRAIN EDEMA; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMODIALYSIS; CORNEA REFLEX; EMERGENCY HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; HYPERAMMONEMIA; LETHARGY; MALE; MEDICATION ERROR; METABOLIC ACIDOSIS; NAUSEA; OSMOLALITY; POTASSIUM BLOOD LEVEL; RESPIRATORY ALKALOSIS; SODIUM BLOOD LEVEL; THORAX RADIOGRAPHY; TOOTH EXTRACTION; TREATMENT OUTCOME; UNCONSCIOUSNESS; UREA CYCLE DISORDER;

ACIDOSIS; ADOLESCENT; AGE OF ONSET; COMA; HUMANS; HYPERAMMONEMIA; MALE; MUTATION; ORNITHINE CARBAMOYLTRANSFERASE; RENAL DIALYSIS; UREA CYCLE DISORDERS, INBORN;

EID: 84856376326     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2011.00591.x     Document Type: Article

References (17)

1. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med. 2007; 356:2282-2292.
2. Praphanphoj V, Boyadjiev SA, Waber LJ, Brusilow SW, Geraghty MT. Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia. J Inherit Metab Dis. 2000; 23:129-136.
3. Yamaguchi S, Brailey Lisa LL, Morizono H, Bale Allen AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat. 2006; 27:626-632.
4. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. THuman Genome Mutation Database (HMGD): 2003 Update. Hum Mutat 2003; 21:577-581.
5. Yue P, Melamud E, Moult J. SNPs3D: Candidate gene and SNP selection for association studies. BMC Bioinformatics. 2006; 7:166.
6. Bourrier P, Varache N, Alquier P, etal. Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase. Presse Med. 1988; 17:2063-2066.
7. Mathias Robert S, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: Role of the nephrologist. Am J Kidney Dis. 2001; 37:1069-1080.
8. Brusilow SW, Maestri NE. Urea cycle disorders: Diagnosis, pathophysiology and therapy. Adv Pediatr. 1996; 43:127-170.
9. Bachmann C. Inherited hyperammonemias. In: Blau N, Duran M, Blaskovics ME and Gibson KM, eds. Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, 2nd edn. Berlin: Springer. 2003; 261-276.
10. Summar M, Barr F, Dawling S, etal. Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin. 2005; 21:S1-S8.
11. Batshaw ML. Hyperammonemia. Curr Probl Pediatr. 1984; 14:1-69.
12. Treem WR. Inherited and acquired syndromes of hyperammonemia and encephalopathy in children. Semin Liver Dis. 1994; 14:236-258.
13. Braissant O. Current concepts in the pathogenesis of urea cycle disorders. Mol Genet Metab. 2010; 100(Suppl 1):S3-S12.
14. Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis. 1998; 21(Suppl 1):S151-S159.
15. Wiegand C, Thompson T, Bock GH, Mathis RK, Kjellstrand CM, Maur SM. The management of life threatening hyperammonemia: A comparison of several therapeutic modalities. J Pediatr. 1980; 96:142-144.
16. Summar M, Tuchman M. Proceedings of a consensus conference for the management of patients with urea cycle disorders. J Pediatr. 2001; 138:S6-10.
17. Batshaw ML, Berry GT. Use of citrulline as a diagnostic marker in the prospective treatment of urea cycle disorders. J Pediatr 1991; 118:914-917.